Year |
Citation |
Score |
2023 |
Ye Z, Bonam SR, McKay LGA, Plante JA, Walker J, Zhao Y, Huang C, Chen J, Xu C, Li Y, Liu L, Harmon J, Gao S, Song D, Zhang Z, ... ... Hu H, et al. Monovalent SARS-COV-2 mRNA vaccine using optimal UTRs and LNPs is highly immunogenic and broadly protective against Omicron variants. Proceedings of the National Academy of Sciences of the United States of America. 120: e2311752120. PMID 38134199 DOI: 10.1073/pnas.2311752120 |
0.356 |
|
2022 |
Yan J, Nie DH, Bai CS, Rehman A, Yang A, Mou XL, Zhang YQ, Xu YQ, Xiang QQ, Ren YT, Xu JL, Wang MR, Feng Y, Chen XP, Xiong Y, ... Hu HT, et al. Fentanyl enhances HIV infection in vitro. Virology. 577: 43-50. PMID 36279602 DOI: 10.1016/j.virol.2022.10.004 |
0.338 |
|
2022 |
Hajnik RL, Plante JA, Liang Y, Alameh MG, Tang J, Bonam SR, Zhong C, Adam A, Scharton D, Rafael GH, Liu Y, Hazell NC, Sun J, Soong L, Shi PY, ... ... Hu H, et al. Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models. Science Translational Medicine. 14: eabq1945. PMID 36103514 DOI: 10.1126/scitranslmed.abq1945 |
0.503 |
|
2022 |
Tang J, Zeng C, Cox TM, Li C, Son YM, Cheon IS, Wu Y, Behl S, Taylor JJ, Chakraborty R, Johnson AJ, Schiavo DN, Utz JP, Reisenauer JS, Midthun DE, ... ... Hu H, et al. Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination. Science Immunology. eadd4853. PMID 35857583 DOI: 10.1126/sciimmunol.add4853 |
0.514 |
|
2021 |
Zhong C, Xia H, Adam A, Wang B, Hajnik RL, Liang Y, Rafael GH, Zou J, Wang X, Sun J, Soong L, Barrett ADT, Weaver SC, Shi PY, Wang T, ... Hu H, et al. Mucosal vaccination induces protection against SARS-CoV-2 in the absence of detectable neutralizing antibodies. Npj Vaccines. 6: 139. PMID 34845215 DOI: 10.1038/s41541-021-00405-5 |
0.329 |
|
2021 |
Zhong C, Liu F, Hajnik RJ, Yao L, Chen K, Wang M, Liang Y, Sun J, Soong L, Hou W, Hu H. Type-I IFN promotes humoral immunity in viral vector vaccination. Journal of Virology. JVI0092521. PMID 34495698 DOI: 10.1128/JVI.00925-21 |
0.364 |
|
2021 |
Alamer E, Zhong C, Hajnik R, Soong L, Hu H. Modulation of BRD4 in HIV epigenetic regulation: implications for finding an HIV cure. Retrovirology. 18: 3. PMID 33413475 DOI: 10.1186/s12977-020-00547-9 |
0.308 |
|
2020 |
Xie L, Chen L, Zhong C, Yu T, Ju Z, Wang M, Xiong H, Zeng Y, Wang J, Hu H, Hou W, Feng Y. MxB impedes the NUP358-mediated HIV-1 pre-integration complex nuclear import and viral replication cooperatively with CPSF6. Retrovirology. 17: 16. PMID 32600399 DOI: 10.1186/S12977-020-00524-2 |
0.397 |
|
2020 |
Alamer E, Zhong C, Liu Z, Niu Q, Long F, Guo L, Gelman BB, Soong L, Zhou J, Hu H. Epigenetic suppression of HIV in myeloid cells by the BRD4-selective small molecule modulator ZL0580. Journal of Virology. PMID 32188727 DOI: 10.1128/Jvi.01880-19 |
0.439 |
|
2019 |
Niu Q, Liu Z, Alamer E, Fan X, Chen H, Endsley J, Gelman BB, Tian B, Kim JH, Michael NL, Robb ML, Ananworanich J, Zhou J, Hu H. Structure-guided drug design identifies a BRD4-selective small molecule that suppresses HIV. The Journal of Clinical Investigation. 130. PMID 31329163 DOI: 10.1172/Jci120633 |
0.432 |
|
2018 |
Auclair S, Liu F, Niu Q, Hou W, Churchyard G, Morgan C, Frahm N, Nitayaphan S, Pitisuthithum P, Rerks-Ngarm S, Kimata JT, Soong L, Franchini G, Robb M, Kim J, ... ... Hu H, et al. Distinct susceptibility of HIV vaccine vector-induced CD4 T cells to HIV infection. Plos Pathogens. 14: e1006888. PMID 29474461 DOI: 10.1371/Journal.Ppat.1006888 |
0.627 |
|
2017 |
Liu F, Niu Q, Fan X, Liu C, Zhang J, Wei Z, Hou W, Kanneganti TD, Robb ML, Kim JH, Michael NL, Sun J, Soong L, Hu H. Priming and Activation of Inflammasome by Canarypox Virus Vector ALVAC via the cGAS/IFI16-STING-Type I IFN Pathway and AIM2 Sensor. Journal of Immunology (Baltimore, Md. : 1950). PMID 28947539 DOI: 10.4049/Jimmunol.1700698 |
0.376 |
|
2016 |
Auclair S, Liu F, Hu H. Loss of immune control in HIV-infected patients: how does mucosal candidiasis occur? Future Microbiology. PMID 27922753 DOI: 10.2217/Fmb-2016-0194 |
0.402 |
|
2016 |
Liu F, Fan X, Auclair S, Ferguson M, Sun J, Soong L, Hou W, Redfield RR, Birx DL, Ratto-Kim S, Robb ML, Kim JH, Michael NL, Hu H. Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection. Plos Pathogens. 12: e1005663. PMID 27280548 DOI: 10.1371/Journal.Ppat.1005663 |
0.571 |
|
2016 |
Li L, Feng H, Da Q, Jiang H, Chen L, Xie L, Huang Q, Xiong H, Luo F, Kang L, Zeng Y, Hu H, Hou W, Feng Y. Expression of HIV-encoded microRNA-TAR and its inhibitory effect on viral replication in human primary macrophages. Archives of Virology. PMID 26831929 DOI: 10.1007/S00705-016-2755-5 |
0.344 |
|
2016 |
Hu H, Liu F, Kim J, Ratto-Kim S. HIV Susceptibility of human antigen-specific CD4 T cells in AIDS pathogenesis and vaccine response. Expert Review of Vaccines. PMID 26814372 DOI: 10.1586/14760584.2016.1147354 |
0.6 |
|
2014 |
Hu H, Eller MA, Zafar S, Zhou Y, Gu M, Wei Z, Currier JR, Marovich MA, Kibuuka HN, Bailer RT, Koup RA, Robb ML, Michael NL, Kim JH, Ratto-Kim S. Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals. Proceedings of the National Academy of Sciences of the United States of America. 111: 13439-44. PMID 25197078 DOI: 10.1073/Pnas.1400446111 |
0.588 |
|
2013 |
Hu H, Nau M, Ehrenberg P, Chenine AL, Macedo C, Zhou Y, Daye ZJ, Wei Z, Vahey M, Michael NL, Kim JH, Marovich M, Ratto-Kim S. Distinct gene-expression profiles associated with the susceptibility of pathogen-specific CD4 T cells to HIV-1 infection. Blood. 121: 1136-44. PMID 23258923 DOI: 10.1186/1742-4690-9-S2-O46 |
0.571 |
|
2011 |
Hu H, Gama L, Aye PP, Clements JE, Barry PA, Lackner AA, Weissman D. SIV antigen immunization induces transient antigen-specific T cell responses and selectively activates viral replication in draining lymph nodes in retroviral suppressed rhesus macaques. Retrovirology. 8: 57. PMID 21752277 DOI: 10.1186/1742-4690-8-57 |
0.614 |
|
2008 |
Hu H, Fernando K, Ni H, Weissman D. HIV envelope suppresses CD4+ T cell activation independent of T regulatory cells. Journal of Immunology (Baltimore, Md. : 1950). 180: 5593-600. PMID 18390744 DOI: 10.4049/Jimmunol.180.8.5593 |
0.635 |
|
2007 |
Fernando K, Hu H, Ni H, Hoxie JA, Weissman D. Vaccine-delivered HIV envelope inhibits CD4(+) T-cell activation, a mechanism for poor HIV vaccine responses. Blood. 109: 2538-44. PMID 17158230 DOI: 10.1182/Blood-2006-08-038661 |
0.646 |
|
Show low-probability matches. |